Murray-Lyon IM - Search Results

1

Discontinuation of pegylated interferon plus ribavirin in patients who are not responding to therapy -- patients' views of early cessation of therapy.

D'Souza R, Main J, Crossey M, Rosenberg W, Murray-Lyon IM, Hayward C, Foster GR. D'Souza R, et al. Among authors: murray lyon im. Aliment Pharmacol Ther. 2005 Jan 1;21(1):43-7. doi: 10.1111/j.1365-2036.2004.02295.x. Aliment Pharmacol Ther. 2005. PMID: 15644044 Clinical Trial.

2

Management of chronic hepatitis C: clinical audit of biopsy based management algorithm.

Foster GR, Goldin RD, Main J, Murray-Lyon I, Hargreaves S, Thomas HC. Foster GR, et al. BMJ. 1997 Aug 23;315(7106):453-8. doi: 10.1136/bmj.315.7106.453. BMJ. 1997. PMID: 9284661 Free PMC article.

3

Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis.

Jacyna MR, Brooks MG, Loke RH, Main J, Murray-Lyon IM, Thomas HC. Jacyna MR, et al. BMJ. 1989 Jan 14;298(6666):80-2. doi: 10.1136/bmj.298.6666.80. BMJ. 1989. PMID: 2493302 Free PMC article. Clinical Trial.

4

Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions.

Khakoo S, Glue P, Grellier L, Wells B, Bell A, Dash C, Murray-Lyon I, Lypnyj D, Flannery B, Walters K, Dusheiko GM. Khakoo S, et al. Br J Clin Pharmacol. 1998 Dec;46(6):563-70. doi: 10.1046/j.1365-2125.1998.00836.x. Br J Clin Pharmacol. 1998. PMID: 9862245 Free PMC article. Clinical Trial.

5

Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots.

Judd A, Parry J, Hickman M, McDonald T, Jordan L, Lewis K, Contreras M, Dusheiko G, Foster G, Gill N, Kemp K, Main J, Murray-Lyon I, Nelson M. Judd A, et al. J Med Virol. 2003 Sep;71(1):49-55. doi: 10.1002/jmv.10463. J Med Virol. 2003. PMID: 12858408

6

Interferon-alpha therapy with and without interferon-alpha priming in patients with chronic hepatitis B infection.

Catterall AP, King R, Lau JY, Daniels HM, Alexander GJ, Murray-Lyon IM, Williams R. Catterall AP, et al. J Antimicrob Chemother. 1993 May;31(5):777-82. doi: 10.1093/jac/31.5.777. J Antimicrob Chemother. 1993. PMID: 8335505 Clinical Trial.

7

Khat chewing delays gastric emptying of a semi-solid meal.

Heymann TD, Bhupulan A, Zureikat NE, Bomanji J, Drinkwater C, Giles P, Murray-Lyon IM. Heymann TD, et al. Aliment Pharmacol Ther. 1995 Feb;9(1):81-3. doi: 10.1111/j.1365-2036.1995.tb00356.x. Aliment Pharmacol Ther. 1995. PMID: 7766749 Clinical Trial.

8

Southern hybridisation analysis of HBV DNA in peripheral blood leucocytes and of different cell types: changes during the natural history and with interferon-alpha therapy in patients with hepatitis B virus infection.

Catterall AP, Murray-Lyon IM, Zuckerman AJ, Harrison TJ. Catterall AP, et al. J Med Virol. 1994 Jul;43(3):269-75. doi: 10.1002/jmv.1890430314. J Med Virol. 1994. PMID: 7931189 Clinical Trial.

9

Dideoxyinosine for chronic hepatitis B infection.

Catterall AP, Moyle GJ, Hopes EA, Harrison TJ, Gazzard BG, Murray-Lyon IM. Catterall AP, et al. J Med Virol. 1992 Aug;37(4):307-9. doi: 10.1002/jmv.1890370414. J Med Virol. 1992. PMID: 1402828

10

A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection.

Gilson RJ, Chopra KB, Newell AM, Murray-Lyon IM, Nelson MR, Rice SJ, Tedder RS, Toole J, Jaffe HS, Weller IV. Gilson RJ, et al. J Viral Hepat. 1999 Sep;6(5):387-95. doi: 10.1046/j.1365-2893.1999.00182.x. J Viral Hepat. 1999. PMID: 10607255 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters